Yttrium-90 radioembolization for advanced hepatocellular carcinoma with Budd-Chiari syndrome: A case report

doi:10.5306/wjco.v16.i5.104762

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series.

Item

Count

PDF

HTML

Figures (1-2)

Sum=0

May 24, 2025 (publication date) through May 19, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Oncol. May 24, 2025; 16(5): 104762
Published online May 24, 2025. doi: 10.5306/wjco.v16.i5.104762

Full Size Figure Download Figure

Figure 2 The result of blood examination change. AFP: Alpha fetoprotein; PIVKA-II: Protein induced by vitamin K absence or antagonist-II; ALB: Albumin; TBIL: Total bilirubin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; PT-INR: Prothrombin time-international normalized ratio.

Citation: Shao MH, Tan BB, Chen HL, Zhang H. Yttrium-90 radioembolization for advanced hepatocellular carcinoma with Budd-Chiari syndrome: A case report. World J Clin Oncol 2025; 16(5): 104762
URL: https://www.wjgnet.com/2218-4333/full/v16/i5/104762.htm
DOI: https://dx.doi.org/10.5306/wjco.v16.i5.104762